Related Experiment Videos
Gastrocystoplasty: long-term complications in 22 patients
G C Mingin1, J A Stock, M K Hanna
1Children's Hospital of New Jersey, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, USA.
The Journal of Urology
|August 24, 1999
Summary
Gastrocystoplasty, a bladder augmentation technique, shows a high rate of late complications (36%) in long-term follow-up. These findings question the overall long-term benefits of using stomach tissue for bladder enlargement.
Area of Science:
- Urology
- Surgical Innovation
- Pediatric Surgery
Background:
- Gastrocystoplasty is an alternative to enterocystoplasty for bladder augmentation.
- It aims to increase bladder capacity and compliance while avoiding bowel-related complications.
- However, gastrocystoplasty carries its own risks, including metabolic and physiological issues.
Observation:
- A retrospective review of 22 patients (12 boys, 10 girls) aged 8-24 years who underwent gastrocystoplasty.
- Follow-up ranged from 48 to 96 months.
- Diagnoses included neurogenic bladder, posterior urethral valves, bladder exstrophy, and pelvic tumor.
Findings:
- The study reported a 36% late complication rate, higher than previously published figures (21.8%).
- Common late complications included vesicoureteral reflux, Mitrofanoff valve stenosis, dysuria-hematuria syndrome, renal calculi, decreased bladder capacity, and metabolic alkalosis.
- Fifty percent of patients with complications experienced multiple issues.
Implications:
- The high rate of long-term complications raises concerns about the sustained efficacy of gastrocystoplasty.
- These findings suggest a need for careful patient selection and long-term monitoring.
- Further research may be warranted to explore alternative bladder augmentation strategies or refine gastrocystoplasty techniques.